Together in diversity: insights and wisdom from LGBTQ+ people working in STEM

“The Queer Variable” is an edited collection of 40 interviews with LGBTQ+ people working in STEM. The interviews reveal the breadth of issues related to exclusion, discrimination, prejudice that LGBTQ+ people face; but also a remarkable progress and advancement of the whole STEM field to be more diverse, inclusive and equitable. The book is an empowering and enlightening reading for all those who are professionally active in STE

Beyond self-confidence: A participatory evaluation of personal change in Science Gallery's Mediators

Mediators engage in peer-to-peer conversations with young adults visiting the art and science exhibitions at Science Gallery Dublin. Previous evaluation and anecdotal reports show that the interdisciplinary nature of these conversations fosters self-confidence and interest in academic careers. We used the Most Significant Change methodology to evaluate if working as a Mediator has an impact beyond these domains. The results show that civic engagement, interest in social justice and emotional empathy are domains of significant personal change strongly associated with the development of self-confidence and interpersonal skills

Beyond self-confidence: a participatory evaluation of personal change in Science Gallery's Mediators

Mediators engage in peer-to-peer conversations with young adults visiting the art and science exhibitions at Science Gallery Dublin. Previous evaluation and anecdotal reports show that the interdisciplinary nature of these conversations fosters self-confidence and interest in academic careers. We used the Most Significant Change methodology to evaluate if working as a Mediator has an impact beyond these domains. The results show that civic engagement, interest in social justice and emotional empathy are domains of significant personal change strongly associated with the development of self-confidence and interpersonal skills

Museums as brokers of participation: how visitors view the emerging role of European science centres and museums in policy

Science centres and museums in Europe traditionally offer opportunities for public participation, such as dialogues, debates and workshops. In recent years, starting with the support of grants from the European Commission, the purpose of these initiatives is increasingly more connected with the policy making processes where science centres play a role as brokers between the public and other stakeholders. This article begins an investigation on how these two levels of participation – the participation of museums in policy, and the participation of visitors in museums – are related in seven European science centres and museums. The results suggest that science centres and museums are regarded by their visitors as potential platforms to facilitate public participation in policy, especially in countries where the general infrastructure for public participation in science is weak

Partizipative Hochschulkommunikation

Der Beitrag stellt den Forschungsstand zu Formen der partizipativen Wissenschafts- und Hochschulkommunikation – z. B. durch Kinderuniversitäten, Tage der offenen Tür, Beteiligungsverfahren usw. – dar. Die Entwicklung derartiger Formate wurde in den vergangenen zwei Jahrzehnten stark politisch gefordert und gefördert. Die Forschung spiegelt diese Entwicklung der Praxis jedoch nur teilweise wider. Vor allem in der deutschsprachigen Literatur werden partizipative, nicht-massenmediale Formen von Wissenschafts- und Hochschulkommunikation allenfalls als Randphänomen wahrgenommen. International ist die Literaturlage seit einigen Jahren hingegen deutlich ergiebiger. Der Beitrag systematisiert diesen Forschungsstand und unterscheidet dabei formatbezogene Ansätze, kritische Ansätze und akteursbezogene Ansätze

LifeTime and improving European healthcare through cell-based interceptive medicine

AUTEURS : LifeTime Community Working GroupsInternational audienceHere we describe the LifeTime Initiative, which aims to track, understand and target human cells during the onset and progression of complex diseases, and to analyse their response to therapy at single-cell resolution. This mission will be implemented through the development, integration and application of single-cell multi-omics and imaging, artificial intelligence and patient-derived experimental disease models during the progression from health to disease. The analysis of large molecular and clinical datasets will identify molecular mechanisms, create predictive computational models of disease progression, and reveal new drug targets and therapies. The timely detection and interception of disease embedded in an ethical and patient-centred vision will be achieved through interactions across academia, hospitals, patient associations, health data management systems and industry. The application of this strategy to key medical challenges in cancer, neurological and neuropsychiatric disorders, and infectious, chronic inflammatory and cardiovascular diseases at the single-cell level will usher in cell-based interceptive medicine in Europe over the next decade

LifeTime and improving European healthcare through cell-based interceptive medicine

LifeTime aims to track, understand and target human cells during the onset and progression of complex diseases and their response to therapy at single-cell resolution. This mission will be implemented through the development and integration of single-cell multi-omics and imaging, artificial intelligence and patient-derived experimental disease models during progression from health to disease. Analysis of such large molecular and clinical datasets will discover molecular mechanisms, create predictive computational models of disease progression, and reveal new drug targets and therapies. Timely detection and interception of disease embedded in an ethical and patient-centered vision will be achieved through interactions across academia, hospitals, patient-associations, health data management systems and industry. Applying this strategy to key medical challenges in cancer, neurological, infectious, chronic inflammatory and cardiovascular diseases at the single-cell level will usher in cell-based interceptive medicine in Europe over the next decade.We would like to acknowledge all participants that have attended and contributed to LifeTime meetings and workshops through many exciting presentations and discussions. We thank Johannes Richers for artwork. LifeTime has received funding from the European Unionʼs Horizon 2020 research and innovation framework programme under Grant agreement 820431